{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:02:08Z","timestamp":1793073728744,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021065","name":"Foundation for Applied Research in Gastrointestinal Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejso.2025.109720","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:58:59Z","timestamp":1740167939000},"page":"109720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery"],"prefix":"10.1016","volume":"51","author":[{"given":"Shadin","family":"Ghabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-7366","authenticated-orcid":false,"given":"Paul H.","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejso.2025.109720_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071732","article-title":"Colorectal cancer: a review of carcinogenesis, global Epidemiology, current challenges, risk factors, preventive and treatment strategies","volume":"14","author":"Hossain","year":"2022","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.ejso.2025.109720_bib2","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Przegl\u0105d Gastroenterol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109720_bib3","first-page":"233","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2025.109720_bib4","unstructured":"Cancer Stat Facts: Colorectal Cancer. https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html."},{"key":"10.1016\/j.ejso.2025.109720_bib5","article-title":"Mechanisms of metastasis in colorectal cancer and metastatic organotropism: hematogenous versus peritoneal spread","volume":"2019","author":"Pretzsch","year":"2019","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.109720_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cllc.2020.04.009","article-title":"Incidence and mortality of lung cancer among never smokers in relationship to secondhand smoking: findings from the PLCO trial","volume":"21","author":"Abdel-Rahman","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2025.109720_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01274232","article-title":"Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment","volume":"373","author":"Sugarbaker","year":"1988","journal-title":"Langenbecks Arch Chir"},{"issue":"10","key":"10.1016\/j.ejso.2025.109720_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/DCR.0000000000002448","article-title":"Clinical and histopathologic features of 35 patients treated for colorectal peritoneal metastases who survived 5 years","volume":"66","author":"Ghabra","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2025.109720_bib9","series-title":"Anesthesia for oncological surgery","article-title":"Hipec","author":"Ghabra","year":"2023"},{"issue":"8","key":"10.1016\/j.ejso.2025.109720_bib10","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","article-title":"Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis","volume":"22","author":"Simkens","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.109720_bib11","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.109720_bib12","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1038\/s41598-024-54917-w","article-title":"Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer","volume":"14","author":"Kamada","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2025.109720_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-024-03429-0","article-title":"Prognostic value of dynamic changes of pre- and post-operative tumor markers in colorectal cancer","author":"Ren","year":"2024","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.109720_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41416-020-0901-z","article-title":"Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer","volume":"123","author":"Lin","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2025.109720_bib15","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.2147\/OTT.S145708","article-title":"Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis","volume":"10","author":"Meng","year":"2017","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ejso.2025.109720_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/bs.pmbts.2018.12.011","article-title":"Serum CEA levels in 49 different types of cancer and noncancer diseases","volume":"162","author":"Hao","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"16","key":"10.1016\/j.ejso.2025.109720_bib17","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.7150\/jca.31375","article-title":"High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy","volume":"10","author":"Zhou","year":"2019","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.109720_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000421-200004000-00021","article-title":"CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen","volume":"23","author":"Mavligit","year":"2000","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.109720_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66652-z","article-title":"Combination of preoperative tumour markers and lymphovascular invasion with TNM staging as a cost and labour efficient subtyping of colorectal cancer","volume":"10","author":"Yamano","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ejso.2025.109720_bib20","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/ijc.32045","article-title":"The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer","volume":"144","author":"Roseweir","year":"2019","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.109720_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3748\/wjg.v22.i5.1745","article-title":"Colorectal cancer tumour markers and biomarkers: recent therapeutic advances","volume":"22","author":"Lech","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109720_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.ejca.2007.03.021","article-title":"Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use","volume":"43","author":"Duffy","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2025.109720_bib23","first-page":"1041","article-title":"Prognostic value of carcinoembryonic antigen (CEA), AFP, CA19-9 and CA125 for patients with colorectal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Huo","year":"2016","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2025.109720_bib24","first-page":"41","article-title":"Can preoperative CEA and CA19-9 serum concentrations suggest metastatic disease in colorectal cancer patients?","volume":"20","author":"Stojkovic Lalosevic","year":"2017","journal-title":"Hellenic J Nucl Med"},{"issue":"4","key":"10.1016\/j.ejso.2025.109720_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4174\/jkss.2013.84.4.231","article-title":"The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer","volume":"84","author":"Yu","year":"2013","journal-title":"J Korean Surg Soc"},{"issue":"5","key":"10.1016\/j.ejso.2025.109720_bib26","first-page":"1251","article-title":"Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer","volume":"12","author":"Yang","year":"2011","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"3","key":"10.1016\/j.ejso.2025.109720_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/modpathol.3880276","article-title":"Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation","volume":"14","author":"Yan","year":"2001","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.ejso.2025.109720_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15092497","article-title":"Signet ring cell colorectal and appendiceal cancer: a small signet ring cell component is also associated with poor outcome","volume":"15","author":"Enblad","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ejso.2025.109720_bib29","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jso.25044","article-title":"Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer","volume":"117","author":"Bagante","year":"2018","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.109720_bib30","first-page":"93","article-title":"The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.ejso.2025.109720_bib31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jso.21679","article-title":"Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin","volume":"102","author":"Sugarbaker","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109720_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/163284","article-title":"Systemic chemotherapy prior to cytoreductive surgery and HIPEC for carcinomatosis from appendix cancer: impact on perioperative outcomes and short-term survival","volume":"2012","author":"Bijelic","year":"2012","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"10.1016\/j.ejso.2025.109720_bib33","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-014-3647-0","article-title":"Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis","volume":"21","author":"Passot","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109720_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"5","key":"10.1016\/j.ejso.2025.109720_bib35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/jso.27370","article-title":"Prognostic indicators for colorectal peritoneal metastases are different for patients with complete versus incomplete cytoreductive surgery","volume":"128","author":"Ghabra","year":"2023","journal-title":"J Surg Oncol"},{"issue":"33","key":"10.1016\/j.ejso.2025.109720_bib36","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejso.2025.109720_bib37","series-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","first-page":"17","article-title":"An overview of peritonectomy, visceral resection, and therapeutic laparoscopy for peritoneal surface malignancy","author":"Sugarbaker","year":"2017"},{"key":"10.1016\/j.ejso.2025.109720_bib38","series-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","first-page":"47","article-title":"Cancer chemotherapy for peritoneal metastases. Pharmacology and treatment","author":"Van der Speeten","year":"2017"},{"key":"10.1016\/j.ejso.2025.109720_bib39","series-title":"Peritoneal carcinomatosis: principles of management","first-page":"415","article-title":"A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor","author":"Sugarbaker","year":"1996"},{"issue":"5","key":"10.1016\/j.ejso.2025.109720_bib40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/02656736.2017.1317368","article-title":"Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay","volume":"33","author":"Sugarbaker","year":"2017","journal-title":"Int J Hyperther"},{"issue":"1","key":"10.1016\/j.ejso.2025.109720_bib41","first-page":"e1","article-title":"What is the optimal preoperative imaging modality for assessing peritoneal cancer index? An analysis from the United States HIPEC collaborative","volume":"19","author":"Lee","year":"2020","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.109720_bib42","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/1097-0142(197612)38:6<2310::AID-CNCR2820380618>3.0.CO;2-L","article-title":"Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer","volume":"38","author":"Sugarbaker","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2025.109720_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.1974.03230260023017","article-title":"Serial carcinoembryonic antigen assays: use in detection of cancer recurrence","volume":"228","author":"Sorokin","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2025.109720_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jso.2930080612","article-title":"Patterns of serial CEA assays and their clinical use in management of colorectal cancer","volume":"8","author":"Sugarbaker","year":"1976","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejso.2025.109720_bib45","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2214\/ajr.127.4.641","article-title":"Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer","volume":"127","author":"Sugarbaker","year":"1976","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ejso.2025.109720_bib46","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00000658-197612000-00016","article-title":"Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer","volume":"184","author":"Sugarbaker","year":"1976","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2025.109720_bib47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0002-9610(77)90143-X","article-title":"Detection of hepatic metastases from cancer of the breast","volume":"133","author":"Sugarbaker","year":"1977","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.109720_bib48","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1038\/s41598-018-21048-y","article-title":"Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer","volume":"8","author":"Gao","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejso.2025.109720_bib49","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1245\/s10434-024-14890-0","article-title":"Preoperative CA19-9 predicts disease progression in colorectal peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an analysis from the US HIPEC Collaborative","volume":"31","author":"Fackche","year":"2024","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T14:49:01Z","timestamp":1753973341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0748798325001489"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109720","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.109720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109720"}}